Assessing the intervention result of BioFreedom stent at 12 and 24 months post-intervention in term of major cardiovascular event (cardiovascular death, stroke, non-fatal myocardial infarction, target vessel revascularization), significant restenosis as well as late and very late in-stent thrombosis Determining several factors affecting independently the intervention outcome using BioFreedom stent (consist of major cardiovascular event and stent restenosis) with statistical significance